Show simple item record

dc.contributor.authorFriend, E
dc.contributor.authorGray, D
dc.contributor.authorOrtega, PF
dc.contributor.authorMcNamara, Mairead G
dc.contributor.authorKaltsas, G
dc.contributor.authorFalconi, M
dc.contributor.authorCwikla, J
dc.contributor.authorCapdevila, J
dc.contributor.authorGlasberg, S
dc.contributor.authorMandair, D
dc.contributor.authorGamper, EM
dc.contributor.authorRamage, J
dc.date.accessioned2020-06-15T12:57:36Z
dc.date.available2020-06-15T12:57:36Z
dc.date.issued2020en
dc.identifier.citationFriend E, Gray D, Ortega P, McNamara MG, Kaltsas G, Falconi M, et al. Development of an EORTC quality of life questionnaire for patients with pancreatic neuroendocrine tumours: phases 1-3. Neuroendocrinology. 2020;110: 303-.en
dc.identifier.urihttp://hdl.handle.net/10541/622959
dc.language.isoenen
dc.titleDevelopment of an EORTC quality of life questionnaire for patients with pancreatic neuroendocrine tumours: phases 1-3en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentHampshire Hospitals NHS Foundation Trust, Basingstokeen
dc.identifier.journalNeuroendocrinologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record